
BACKGROUND Benign suprasellar arachnoid cysts (SACs) arise from arachnoid membranes and are filled with cerebrospinal fluid (CSF). Their location can cause obstructive hydrocephalus, endocrine dysfunction, or visual compromise. This study assessed the outcomes of endoscopic ventriculocystocisternotomy (VCC) in patients with SACs and to provide insights into cyst characteristics and their surgical management. METHODS This retrospective cohort study included 74 patients with SACs who underwent endoscopic VCC between June 1993 and December 2024. Video recordings of the surgery, medical records detailing the procedure, and clinical data were all reviewed. Preoperative and one-year postoperative cyst volumes and Evans' indices were compared. RESULTS The median age at presentation was 6 (range: <1-22 years), with a slight male preponderance (69%). The most frequent presentations included nausea and vomiting (88%), followed by headache and papilledema (65% each). At one-year postoperative follow-up, the majority of patients (74%) achieved complete resolution, while 16% of patients showed partial improvement, and 9.5% experienced no improvement. Significant reduction in cyst dimensions and volume was achieved, with large effect sizes (all p-values <0.05). No significant morbidity or mortality was recorded, except for CSF leakage in three patients. CONCLUSIONS In patients with SACs, VCC showed good efficacy through targeting both cyst fenestration and hydrocephalus (74% clinical success rate). No procedure-related mortality or significant morbidity was reported. Future multicenter longitudinal studies are required to assess factors that impact the success of VCC and compare its efficacy and safety to ventriculocystostomy in patients with SACs.